Clinical Trial Update: QA108 Phase II Study in Subjects With Intermediate Age-Related Macular Degeneration [Phase 2]

View source ↗

Summary

QA108 in subjects with intermediate age-related macular degeneration has completed its Phase II study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• QA108

Snippet

Sponsor: Smilebiotek Zhuhai Limited | Conditions: Intermediate Age-Related Macular Degeneration | Phase 2 | Status: COMPLETED